Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trastuzumab and breast cancer.

× No keyword cloud information.

41 in total

1. Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models.

Authors: Zhaofei Liu; Bing Jia; Huiyun Zhao; Xiaoyuan Chen; Fan Wang
Journal: Mol Imaging Biol Date: 2011-02 Impact factor: 3.488

2. Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules.

Authors: Vladimir Tolmachev; Heng Xu; Helena Wållberg; Sara Ahlgren; Magnus Hjertman; Anna Sjöberg; Mattias Sandström; Lars Abrahmsén; Martin W Brechbiel; Anna Orlova
Journal: Bioconjug Chem Date: 2008-07-12 Impact factor: 4.774

3. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.

Authors: Scott M Knowles; Anna M Wu
Journal: J Clin Oncol Date: 2012-09-17 Impact factor: 44.544

Review 4. Noninvasive imaging of cardiovascular injury related to the treatment of cancer.

Authors: Suwat Kongbundansuk; W Gregory Hundley
Journal: JACC Cardiovasc Imaging Date: 2014-08

5. Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

Authors: Torun Engfeldt; Anna Orlova; Thuy Tran; Alexander Bruskin; Charles Widström; Amelie Eriksson Karlström; Vladimir Tolmachev
Journal: Eur J Nucl Med Mol Imaging Date: 2006-12-05 Impact factor: 9.236

Review 6. Receptor Occupancy Imaging Studies in Oncology Drug Development.

Authors: Ingrid J G Burvenich; Sagun Parakh; Adam C Parslow; Sze Ting Lee; Hui K Gan; Andrew M Scott
Journal: AAPS J Date: 2018-03-08 Impact factor: 4.009

7. Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines.

Authors: Jennie Malmberg; Vladimir Tolmachev; Anna Orlova
Journal: Exp Ther Med Date: 2011-02-22 Impact factor: 2.447

Review 8. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

Authors: Kate McKeage; Caroline M Perry
Journal: Drugs Date: 2002 Impact factor: 9.546

Review 9. Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?

Authors: Timothy M Markman; Maurie Markman
Journal: Curr Oncol Rep Date: 2014 Impact factor: 5.075

10. ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.

Authors: Frances Belmonte; Samarjit Das; Polina Sysa-Shah; Vidhya Sivakumaran; Brian Stanley; Xin Guo; Nazareno Paolocci; Miguel A Aon; Masaki Nagane; Periannan Kuppusamy; Charles Steenbergen; Kathleen Gabrielson
Journal: Am J Physiol Heart Circ Physiol Date: 2015-08-07 Impact factor: 4.733